.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Healthtrust
Cipla
Daiichi Sankyo
Novartis
Cantor Fitzgerald
Citi
Merck
Colorcon
Baxter

Generated: July 26, 2017

DrugPatentWatch Database Preview

Sonidegib phosphate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for sonidegib phosphate and what is the scope of sonidegib phosphate freedom to operate?

Sonidegib phosphate
is the generic ingredient in one branded drug marketed by Sun Pharma Global and is included in one NDA. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Sonidegib phosphate has ninety patent family members in forty-five countries.

There are two drug master file entries for sonidegib phosphate. One supplier is listed for this compound.

Summary for Generic Name: sonidegib phosphate

Tradenames:1
Patents:2
Applicants:1
NDAs:1
Drug Master File Entries: see list2
Suppliers / Packagers: see list1
Clinical Trials: see list791
Drug Prices:see low prices
DailyMed Link:sonidegib phosphate at DailyMed

Pharmacology for Ingredient: sonidegib phosphate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharma Global
ODOMZO
sonidegib phosphate
CAPSULE;ORAL205266-001Jul 24, 2015RXYesYes► Subscribe► SubscribeY ► Subscribe
Sun Pharma Global
ODOMZO
sonidegib phosphate
CAPSULE;ORAL205266-001Jul 24, 2015RXYesYes► Subscribe► Subscribe► Subscribe
Sun Pharma Global
ODOMZO
sonidegib phosphate
CAPSULE;ORAL205266-001Jul 24, 2015RXYesYes► Subscribe► SubscribeYY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: sonidegib phosphate

Country Document Number Estimated Expiration
South Korea101076943► Subscribe
Russian Federation2413718► Subscribe
El Salvador2008003089► Subscribe
Portugal2363393► Subscribe
Morocco32717► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.



Supplementary Protection Certificates for Tradename: SONIDEGIB PHOSPHATE

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2015 00057Denmark► SubscribePRODUCT NAME: SONIDEGIB ELLER ET FARMACEUTISK ACCEPTABELT SALT, HYDRAT ELLER SOLVAT DERAF, HERUNDER SONIDEGIBFOSFAT; REG. NO/DATE: EU/1/15/1030 20150818
C0077France► SubscribePRODUCT NAME: SONIDEGIB OU SEL,HYDRATE,OU SOLVATE PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI; REGISTRATION NO/DATE: EU/1/15/1030 20150818
2015051Lithuania► SubscribePRODUCT NAME: SONIDEGIBUM; REGISTRATION NO/DATE: EU/1/15/1030 20150818
883Luxembourg► SubscribePRODUCT NAME: SONIDEGIB OU UN SEL, HYDRATE OU SOLVATE PHARMACEUTIQUEMENT ACCEPTABLE QUI EN DERIVE; FIRST REGISTRATION: 20150818
2016000001Germany► SubscribePRODUCT NAME: SONIDEGIB ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ, HYDRAT ODER SOLVAT HIERVON; REGISTRATION NO/DATE: EU/1/15/1030 20150814
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Deloitte
Johnson and Johnson
US Army
Argus Health
Citi
Cantor Fitzgerald
Healthtrust
Queensland Health
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot